Outcomes4Me is a founding member of CancerX, an initiative of the Cancer Moonshot Learn more >

/ August 29, 2022
At the recent 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, the DESTINY-Breast04 trial...